Pimecrolimus

Primary Uses

Pimecrolimus is primarily used to treat the skin condition known as atopic dermatitis, which is a common form of eczema. It helps reduce symptoms such as redness, itching, and inflammation.

When It Is Prescribed

This medication is generally considered a second-line treatment. This means it is typically used for patients who:

• Have not responded well to other treatments, such as topical steroids.
• Cannot use other standard treatments due to side effects or other medical reasons.

It is approved for use in adults and children who are at least 2 years old. It is intended for short-term use or intermittent long-term use to manage flare-ups of the condition. It is not meant for continuous, long-term use.

How It Works

As a topical calcineurin inhibitor, pimecrolimus works by affecting the immune system's response in the skin. By suppressing certain cells that cause inflammation, it helps clear up skin rashes and relieves the discomfort associated with eczema.

How Pimecrolimus Works

Pimecrolimus belongs to a class of medications known as topical calcineurin inhibitors. It is used to manage the symptoms of atopic dermatitis, commonly known as eczema, by altering the way the immune system reacts to triggers that cause skin irritation.

In people with eczema, the immune system overreacts to certain substances, causing the skin to release chemicals that lead to redness, swelling, and intense itching. Pimecrolimus works by blocking a specific protein in the skin called calcineurin. This protein is a key part of the process that activates immune cells.

By blocking this protein, the medication helps to:

• Prevent the release of chemicals that cause inflammation in the skin cells.
• Reduce the redness and swelling associated with eczema flares.
• Relieve the urge to scratch by calming skin irritation.

Because pimecrolimus is applied directly to the skin, it primarily works to control the immune response in the treated area rather than affecting the entire body.

Common Side Effects

• Burning, stinging, or a feeling of warmth where the medication was applied
• Headache
• Fever
• Cough or sore throat
• Runny or stuffy nose
• Flu-like symptoms
• Acne or small red bumps on the skin (folliculitis)
• Upset stomach or muscle pain

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following:

• Signs of a skin infection, such as blisters, oozing, or yellow crusting
• New or worsening skin growths, warts, or changes in moles
• Swollen glands (lymph nodes) in the neck, armpit, or groin
• Severe skin rash or worsening of eczema
• Ear pain or drainage
• Eye redness, swelling, or irritation
• Signs of an allergic reaction, including hives, difficulty breathing, or swelling of the face, lips, or throat

Drinking alcohol while using pimecrolimus may cause the skin or face to become flushed, red, or hot. This reaction is usually temporary but should be reported to a doctor if it is bothersome.

Boxed Warning

The FDA has issued a boxed warning for pimecrolimus because the long-term safety of topical calcineurin inhibitors has not been fully established. While a direct link has not been proven, rare cases of cancer, including skin cancer and lymphoma, have been reported in patients using this medication. Because of this potential risk, pimecrolimus is only intended for short-term or intermittent treatment of eczema when other therapies have failed or are not appropriate.

Usage Restrictions

• Age limits: This medication is not approved for use in children younger than 2 years of age.
• Immune system: People with weakened immune systems or those taking medications that suppress the immune system should not use pimecrolimus.
• Skin conditions: It should not be applied to areas of the skin that are infected with viruses (such as herpes or chickenpox), bacteria, or fungi. It is also not recommended for people with certain rare skin conditions, such as Netherton's syndrome, which can increase the amount of medicine absorbed into the body.

Sun and UV Exposure

Pimecrolimus may make the skin more sensitive to light. It is important to limit exposure to natural sunlight and avoid artificial sunlight, such as tanning beds or UV light therapy, while using this cream. If outdoor activity is necessary, protective clothing or sunscreens should be used on the treated areas.

Monitoring and Other Precautions

Healthcare providers may monitor for swollen lymph nodes (lymphadenopathy) during treatment. If lymph nodes become enlarged or if an infection develops, the medication may need to be stopped. Patients should also avoid covering the treated area with bandages, dressings, or wraps unless specifically instructed by a healthcare professional.

Pregnancy

There are no adequate and well-controlled studies of pimecrolimus in pregnant women. While animal studies using high oral doses have shown some risks to the developing fetus, the amount of medication absorbed through the skin into the bloodstream is generally very low. Because human data is limited, pimecrolimus should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is not known whether pimecrolimus passes into human breast milk after topical application. Because many drugs are excreted in human milk, caution is recommended when using this medication while breastfeeding. To minimize risk to the nursing infant, avoid applying the cream to the breast area to prevent the baby from accidentally swallowing the medication or coming into direct contact with it.

Consult Your Doctor

If you are pregnant, planning to become pregnant, or breastfeeding, talk to your healthcare provider before using pimecrolimus. They can help determine if this treatment is appropriate for your specific situation based on the severity of your condition and the potential risks involved.

Dosage Forms

Pimecrolimus is available as a topical cream. This medication is intended for application directly to the skin in areas affected by eczema.

Strengths

Pimecrolimus cream is available in the following strength:

• Cream: 1%

FDA Approval and Indications

Pimecrolimus is FDA-approved for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children 2 years of age and older. It is specifically indicated for patients who do not have a weakened immune system and who have not responded well to other topical treatments.

Boxed Warning

This medication carries a boxed warning, which is the most serious warning required by the FDA. This warning is based on rare reports of cancer, such as skin cancer and lymphoma, in patients treated with this class of drugs. Because of this potential risk, the following safety measures are required:

• The medication should only be used as a second-line treatment when other therapies are not appropriate or have failed.
• It is not approved for use in children under the age of 2.
• Continuous, long-term use should be avoided.
• Application should be limited to areas of the skin affected by eczema.

Additional Regulatory Information

The FDA advises that pimecrolimus should not be used on skin areas that have active viral infections, such as chickenpox or herpes. Patients are also advised to minimize exposure to natural or artificial sunlight during treatment.

Generic vs. Brand Name

Pimecrolimus is available as a generic medication and under the brand name Elidel. Generic versions of medications typically cost less than brand-name products. Both the generic and brand-name versions require a prescription from a healthcare provider.

Insurance and Coverage

Most insurance plans provide coverage for pimecrolimus, though the level of coverage can vary. Some plans may prefer the generic version or require specific authorization before covering the brand-name product. Out-of-pocket costs, such as copays or coinsurance, are determined by individual insurance policies.

Factors Influencing Price

• Tube Size: Pimecrolimus cream is commonly available in different sizes, such as 30-gram, 60-gram, or 100-gram tubes, which affects the total price.
• Pharmacy Choice: Prices for the same medication can vary between different retail pharmacies and mail-order services.
• Patient Assistance: Some manufacturers may offer savings programs or assistance for eligible patients to help manage the cost of the medication.